Vascular effects of serelaxin in patients with stable coronary artery disease: a randomized placebo-controlled trial

AIMS: The effects of serelaxin, a recombinant form of human relaxin-2 peptide, on vascular function in the coronary microvascular and systemic macrovascular circulation remain largely unknown. This mechanistic, clinical study assessed the effects of serelaxin on myocardial perfusion, aortic stiffnes...

Descripción completa

Detalles Bibliográficos
Autores principales: Corcoran, David, Radjenovic, Aleksandra, Mordi, Ify R, Nazir, Sheraz A, Wilson, Simon J, Hinder, Markus, Yates, Denise P, Machineni, Surendra, Alcantara, Jose, Prescott, Margaret F, Gugliotta, Barbara, Pang, Yinuo, Tzemos, Niko, Semple, Scott I, Newby, David E, McCann, Gerry P, Squire, Iain, Berry, Colin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797213/
https://www.ncbi.nlm.nih.gov/pubmed/32065620
http://dx.doi.org/10.1093/cvr/cvz345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797213/
https://www.ncbi.nlm.nih.gov/pubmed/32065620
http://dx.doi.org/10.1093/cvr/cvz345

Ejemplares similares